Takeda Pharmaceutical Co Ltd ADR (TAK)

14.20 0.00 (0.00%)
Closed USD Disclaimer
14.00 -0.20 (-1.41%)

TAK Financial Summary

Takeda Pharmaceutical Company Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was JPY 972,465 million compared to JPY 949,603 million a year ago. Net income was JPY 105,014 million compared to JPY 137,684 million a year ago. Basic earnings per share from continuing operations was JPY 67.94 compared to JPY 87.96 a year ago. Diluted earnings per share from continuing operations was JPY 67.56 compared to JPY 87.45 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
TAK
Gross margin TTM 67.18%
Operating margin TTM 13.96%
Net Profit margin TTM 5.5%
Return on Investment TTM 3.86%
Total Revenue
Net Income
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Total Revenue 972,465 901,294 844,819
Gross Profit 679,583 619,890 569,022
Operating Income 150,516 116,484 97,427
Net Income 105,014 57,769 45,964
Clear All
0Selected
Please try another search
TAK
Quick Ratio MRQ 0.65
Current Ratio MRQ 1.18
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 80.91%
Total Assets
Total Liabilities
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Total Assets 14,065,426 13,178,018 12,698,519 12,560,273
Total Liabilities 7,748,043 7,494,495 7,367,190 7,236,338
Total Equity 6,317,383 5,683,523 5,331,329 5,323,935
Clear All
0Selected
Please try another search
TAK
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow 3.89%
Cash
Net Change in Cash
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Cash From Operating Activities 84,241 747,521 400,011
Cash From Investing Activities -94,714 -172,487 -103,349
Cash From Financing Activities -215,717 -826,465 -658,405
Net Change in Cash -241,882 -358,341
Clear All
0Selected
Please try another search

* In Millions of JPY (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.